Verano Holdings Corp.
Verano Holdings Corp. (VRNOF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
vrnof · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Verano Holdings Corp.You VRNOF | $470M | N/A | — | — |
 Allergy Therapeutics plc AGYTF | $655M | N/A | — | -$0.01 |
 Craftport Cannabis Corp. BHHKF | $0M | N/A | — | -$0.49 |
 COLTENE Holding AG CLHLF | $456M | 19.50x | +76.2% | $2.49 |
 Cresco Labs Inc. CRLBF | $332M | N/A | — | -$0.42 |
 Glass House Brands Inc. GLASF | $1.0B | N/A | — | -$0.40 |
 Hua Medicine (Shanghai) Ltd. HUMDF | $431M | 2.63x | -76.2% | $1.09 |
Industry Average 2 peers with valid PE | — | 11.07x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Verano Holdings Corp. (VRNOF) measures how much investors pay for each dollar of the company's trailing earnings. VRNOF's current PE ratio of N/A is calculated by dividing its stock price of $1.30 by its TTM earnings per share of —.
Frequently asked questions
VRNOF pe ratio · 6 questionsVRNOF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.30 and TTM EPS of —. Data sourced from Financial Modeling Prep via VRNOF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Verano Holdings Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09